Logo

kidney disease

RenalytixAI, Wake Forest, Atrium Health Partner on Kidney Health Initiative

RenalytixAI will offer its KidneyIntelX platform through Atrium Health's electronic health record system at 37 hospitals across the Carolinas and Georgia.

Renalytix AI Lands US Government Contract for Kidney Disease Test

The firm said that the contract covers early-stage kidney disease testing that can be provided by more than 140 US government departments, agencies, and affiliates.

PNAS Papers on Acute Kidney Injury, Parental Expression in Horse Placenta, Sea Urchin Microbes

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.

NephroSant Readies Launch of Kidney Transplant Rejection Assay
Premium

Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications.  

Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy
Premium

Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise.

Feb 24, 2021

RenalytixAI Inks Deal to Introduce Kidney Function Testing Platform at University of Utah Health

Jan 22, 2021

Fresenius Building Large Renal Genomic Registry to Inform Precision Care for Kidney Disease
Premium

Jan 19, 2021

Blood, Urine Biomarker Study Leads to Linked Loci, Disease-Related Risk Scores

Dec 2, 2020

Bio-Techne, Regulus Therapeutics to Develop Assays for Kidney Disease Treatment

Nov 3, 2020

Natera Aims to Improve Prospera Kidney Test After Findings Reveal Cell-Free DNA Changes in Infection
Premium

Aug 21, 2020

RenalytixAI, AstraZeneca Ink Agreement to Enhance Chronic Disease Patient Outcomes

Jun 30, 2020

RenalytixAI Inks Kidney Disease Dx Deals With University of Michigan, Global Pharmaceutical Firm

Jun 12, 2020

RenalytixAI Receives Approval From New York State to Offer Kidney Test

Apr 28, 2020

RenalytixAI, Mount Sinai Launch Study to Predict COVID-19 Kidney Complications
Premium

Mar 18, 2020

Nephrosant Eyes Launch of Urine-Based Kidney Transplantation Rejection Risk Assay
Premium

Mar 17, 2020

Viracor Eurofins, National Kidney Registry Partner to Provide SARS-CoV-2 Testing

Feb 18, 2020

Natera Countersues CareDx for False Advertising

Jan 21, 2020

Urinary Metabolite GWAS Leads to Risk Variants, Potential Markers of Kidney Disease

Jan 8, 2020

Magistrate Judge Recommends Partial Rejection of Natera Motion to Dismiss CareDx False Advertising Lawsuit

Dec 19, 2019

Natera Obtains Final Medicare Local Coverage Determination for Kidney Transplant Test From Palmetto

Dec 6, 2019

Local Coverage Determinations Roundup: Transplant Genomics, Opko Health

Oct 31, 2019

CareDx Q3 Revenues Up 60 Percent

Oct 2, 2019

Liquid Biopsy Test Targets Early Detection of Diabetes Complications, Cancers
Premium

Sep 26, 2019

Human Kidney Immune Cell Map Reveals Multiple Infection Protection Zones

Sep 20, 2019

GWAS in Diabetes Patients Uncovers Risk Loci for Kidney Disease

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.